These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 12471457)

  • 1. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated microglia do not mediate the early deposition of Abeta in carriers of the apolipoprotein Eepsilon4 allele.
    Vogelgesang S; Schroeder E; Walker LC; Pahnke J; Naubereit A; Walther R; Stausske D; Warzok RW
    Clin Neuropathol; 2002; 21(3):99-106. PubMed ID: 12049183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE, vascular pathology, and the AD brain.
    Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
    Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
    Dodart JC; Marr RA; Koistinaho M; Gregersen BM; Malkani S; Verma IM; Paul SM
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1211-6. PubMed ID: 15657137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy.
    Christoforidis M; Schober R; Krohn K
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):11-9. PubMed ID: 15634227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
    Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
    Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD?
    Persson J; Lind J; Larsson A; Ingvar M; Cruts M; Van Broeckhoven C; Adolfsson R; Nilsson LG; Nyberg L
    Neurology; 2006 Apr; 66(7):1029-33. PubMed ID: 16606914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
    Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM
    Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease.
    Reynolds WF; Rhees J; Maciejewski D; Paladino T; Sieburg H; Maki RA; Masliah E
    Exp Neurol; 1999 Jan; 155(1):31-41. PubMed ID: 9918702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
    Dolev I; Michaelson DM
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.